The LMNA Gene Cardiomyopathy Dilated Type 1A Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the LMNA gene, which are associated with Dilated Cardiomyopathy Type 1A (DCM1A). Dilated cardiomyopathy is a condition characterized by the enlargement and weakening of the heart's ventricles, which can lead to heart failure and arrhythmias. The LMNA gene plays a critical role in encoding proteins that are essential for the structural stability and function of cells, including heart muscle cells. Mutations in this gene can disrupt these processes, contributing to the development of cardiomyopathy.
This genetic test is crucial for individuals with a family history of dilated cardiomyopathy or those exhibiting symptoms of the condition, as it can provide a definitive diagnosis and help in tailoring the appropriate management and treatment strategies. Early detection through genetic testing can significantly impact the clinical outcome by enabling proactive measures to prevent or minimize the progression of the disease.
The test is performed using a blood sample from the patient, which is then analyzed for specific genetic variations in the LMNA gene that are known to cause DCM1A. The cost of the LMNA Gene Cardiomyopathy Dilated Type 1A Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity of genetic testing and the critical information it provides, this test represents a valuable investment in an individual's health, offering a pathway to personalized medicine and targeted treatment options for those affected by or at risk of developing dilated cardiomyopathy.
The ACTN2 gene plays a critical role in the structure and function of heart muscle cells, and mutations in this gene are associated with dilated cardiomyopathy type 1AA, a condition characterized by the enlargement and weakening of the heart's main pumping chamber. The ACTN2 Gene Cardiomyopathy Dilated Type 1AA Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the ACTN2 gene that may predispose individuals to this specific type of heart disease.
By analyzing a sample of the patient's DNA, this test can identify the presence of genetic variations that are linked to dilated cardiomyopathy type 1AA, providing crucial information for early diagnosis, management, and treatment planning. The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, where advanced genetic testing technologies ensure accurate and reliable results. This test is particularly recommended for individuals with a family history of cardiomyopathy or unexplained heart failure, as it can help in taking preemptive health measures and informing family planning decisions.
The DSG2 Gene Cardiomyopathy Dilated Type 1BB Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the DSG2 gene, which have been associated with dilated cardiomyopathy (DCM) type 1BB. Dilated cardiomyopathy is a condition characterized by the enlargement and weakening of the heart's main pumping chamber, leading to decreased heart function and, in severe cases, heart failure. The DSG2 gene plays a crucial role in the structure and function of heart muscle cells, and mutations in this gene can disrupt heart muscle function, contributing to the development of DCM.
This genetic test is particularly valuable for individuals with a family history of dilated cardiomyopathy or unexplained heart failure, as it can provide a definitive diagnosis of DCM type 1BB. Early detection through genetic testing allows for timely intervention and management of the condition, potentially improving outcomes for affected individuals.
The test is conducted at DNA Labs UAE, a facility known for its advanced genetic testing services. The cost of the DSG2 Gene Cardiomyopathy Dilated Type 1BB Genetic Test is 4400 AED, reflecting the sophisticated nature of the testing process and the specialized expertise required to interpret the results. This test is an important resource for individuals and families seeking clarity on their genetic risk for dilated cardiomyopathy, enabling them to make informed decisions about their health and care.
The LDB3 gene, associated with Cardiomyopathy Dilated Type 1C, plays a crucial role in maintaining the structural integrity and function of cardiac muscle. Mutations in this gene can lead to the development of dilated cardiomyopathy (DCM), a condition characterized by the enlargement and weakening of the heart's left ventricle, which impairs the heart's ability to pump blood efficiently.
The genetic test for LDB3 gene-associated Cardiomyopathy Dilated Type 1C is a vital diagnostic tool aimed at identifying individuals carrying mutations in the LDB3 gene. This test is particularly important for those with a family history of cardiomyopathy or individuals showing symptoms of the condition, as early detection can lead to more effective management and treatment strategies.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the patient's DNA to detect mutations in the LDB3 gene that are known to cause Cardiomyopathy Dilated Type 1C. The process is thorough and ensures a high degree of accuracy in the results.
The cost of the LDB3 Gene Cardiomyopathy Dilated Type 1C Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of the information it provides cannot be overstated, especially for individuals at risk of developing this serious heart condition. Early diagnosis through this genetic test can significantly impact treatment decisions and potentially improve the quality of life and outcomes for affected individuals.
The "NEXN Gene Cardiomyopathy Dilated Type 1CC Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the NEXN gene that are associated with Dilated Cardiomyopathy (DCM) of type 1CC. DCM is a condition characterized by the enlargement and weakening of the heart's main pumping chamber, which can lead to heart failure and other serious complications. The NEXN gene plays a crucial role in the structural integrity and function of heart muscle cells, and mutations in this gene can disrupt these processes, leading to the development of DCM.
The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to identify any genetic alterations in the NEXN gene. It is particularly useful for individuals with a family history of DCM or those exhibiting symptoms suggestive of the condition, as early detection can enable timely intervention and management strategies to mitigate the progression of the disease.
Offered at a cost of 4400 AED, this genetic test is a significant advancement in the field of personalized medicine, allowing for a more tailored approach to the diagnosis, treatment, and management of Dilated Cardiomyopathy. DNA Labs UAE, with its state-of-the-art facilities and expertise in genetic diagnostics, provides a reliable and efficient service for individuals seeking to understand their genetic risk for this condition.
The TNNT2 gene plays a crucial role in the structure and function of the heart muscle, and mutations in this gene are associated with dilated cardiomyopathy type 1D (DCM1D), a condition characterized by the enlargement and weakening of the heart's left ventricle, leading to reduced heart function. The TNNT2 Gene Cardiomyopathy Dilated Type 1D Genetic Test is a specialized diagnostic tool designed to identify mutations in the TNNT2 gene, providing crucial information for the diagnosis, treatment planning, and familial risk assessment of DCM1D.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, this test is a critical resource for individuals with a family history of dilated cardiomyopathy or those exhibiting symptoms of the condition. The test cost is 4400 AED, reflecting the comprehensive analysis and the sophisticated technology employed to accurately detect the specific genetic alterations within the TNNT2 gene. By opting for this test, patients and healthcare providers can gain valuable insights into the genetic underpinnings of dilated cardiomyopathy, enabling informed decisions regarding management and therapy options, as well as the potential need for family member testing to assess inherited risks.
The RBM20 Gene Cardiomyopathy Dilated Type 1DD Genetic Test is a specialized diagnostic assessment designed to detect mutations in the RBM20 gene, which are associated with Dilated Cardiomyopathy (DCM) Type 1DD. This condition is a form of heart disease characterized by the enlargement and weakening of the heart's main pumping chamber, leading to decreased heart function and, potentially, heart failure. The test plays a crucial role in early detection, allowing for timely intervention and management of the condition.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, this test involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab. The sample is then analyzed for specific genetic mutations in the RBM20 gene known to contribute to the development of Dilated Cardiomyopathy.
The cost of the RBM20 Gene Cardiomyopathy Dilated Type 1DD Genetic Test is set at 4400 AED. This price reflects the comprehensive nature of the test, covering the cost of sample collection, genetic analysis, and the provision of a detailed report by the laboratory's genetic specialists. The report not only confirms the presence or absence of the RBM20 mutation but also provides insights into the patient's risk of developing the condition and guidance for clinical management.
Given the genetic basis of Type 1DD Dilated Cardiomyopathy, this test is particularly valuable for individuals with a family history of the condition, offering them an opportunity for early detection and the adoption of preventive health measures.
The SCN5A Gene Cardiomyopathy Dilated Type 1E Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the SCN5A gene, which are associated with Dilated Cardiomyopathy Type 1E (DCM1E). This condition is a form of heart disease that affects the heart's ability to pump blood efficiently, leading to heart enlargement and impaired systolic function. The test is crucial for early detection, enabling personalized treatment plans and management strategies to mitigate the risk of heart failure and other complications.
Priced at 4400 AED, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities in the SCN5A gene. By identifying these mutations, healthcare providers can offer targeted interventions, potentially improving outcomes for individuals with a predisposition to DCM1E. This genetic test is an invaluable resource for individuals with a family history of cardiomyopathy or unexplained heart failure, providing insights into their genetic health and guiding clinical decisions.
The MYH6 gene cardiomyopathy dilated type 1EE genetic test is a specialized diagnostic procedure designed to detect mutations in the MYH6 gene, which are implicated in causing dilated cardiomyopathy type 1EE. Dilated cardiomyopathy is a condition characterized by the enlargement and weakening of the heart's main pumping chamber, leading to reduced heart function and potentially severe cardiovascular complications. The MYH6 gene plays a critical role in the heart's muscular structure, and mutations in this gene can disrupt normal heart function, leading to the development of cardiomyopathy.
This genetic test is crucial for individuals with a family history of cardiomyopathy or those exhibiting symptoms suggestive of this condition, as it can provide a definitive diagnosis and help guide treatment decisions. Early identification of the genetic mutation allows for timely intervention, which can significantly improve the management of the disease and the quality of life for affected individuals.
The test is available at DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the MYH6 gene cardiomyopathy dilated type 1EE genetic test is 4400 AED. By offering this test, DNA Labs UAE provides a valuable resource for patients and healthcare providers seeking to understand the genetic basis of cardiomyopathy and tailor treatment strategies accordingly.
The TTN Gene Cardiomyopathy Dilated Type 1G Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the TTN gene, which are associated with Dilated Cardiomyopathy (DCM) type 1G. This condition is characterized by the enlargement of the heart's ventricles, leading to impaired cardiac function and, if left untreated, can result in heart failure and other severe cardiovascular complications. The test is particularly valuable for individuals with a family history of DCM or those presenting symptoms suggestive of cardiomyopathy, as early detection can significantly impact management and treatment options. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the genetic variations linked to this condition. Conducted at DNA Labs UAE, a facility known for its commitment to precision and healthcare excellence, this genetic test represents a crucial step towards personalized medicine in the field of cardiology, enabling tailored treatment plans that address the specific needs of individuals with TTN gene mutations.
